Ciro Santilli @cirosantilli 37

A network interface controller that does more than just the base OSI model protocols, notably in a programmable way.

When you see some tagged examples, you will immediately know what this means.

Predecessor to the synchrotron.

During the early 2020s, many of the idiotic social media platforms started adding a non optional "feature" of suggesting feed posts by people you don't follow:

It must have been some A/B testing overload that made that decision to try and make things more addictive for everyone. Or perhaps as a way to drive revenue with people paying to cheat the algorithm and boost their posts.

European Union we need you.

The definition implies that this is also a symmetric matrix.

Ciro Santilli once visited the chemistry department of a world leading university, and the chemists there were obsessed with NMR. They had small benchtop NMR machines. They had larger machines. They had a room full of huge machines. They had them in corridors and on desk tops. Chemists really love that stuff. More precisely, these are used for NMR spectroscopy, which helps identify what a sample is made of.

Basically measures the concentration of certain isotopes in a region of space.

Ciro Santilli's raison d'etre, one of his attempts: OurBigBook.com.

The outcome of closed knowledge is reverse engineering.

Bought by Illumina for 600 million in 2007 for 600 million dollars.

This is one of the prime examples of Europe's decline.

Instead of trying to dominate the sequencing market and gain trillions of dollars from it, they local British early stage investors were more than happy to get a 20x return on their small initial investments, and sold out to the Americans who will then make the real profit.

And now Solexa doesn't even have its own Wikipedia page, while Illumina is set out to be the next Microsoft. What a disgrace.

Here are some good articles about the company:

Cambridge visitors can still visit the Panton Arms pub, which was the location of the legendary "hey we should talk" founders meeting, chosen due to its proximity to the chemistry department of the University of Cambridge.

In 2021 the founders were awarded the Breakthrough Prize. The third person awarded was Pascal Mayer. He was apparently at Serono Pharmaceutical Research Institute at the time of development. They do have a wiki page unlike Solexa: en.wikipedia.org/wiki/Serono. They paid a 700 million fine in 2005 in the United States, and sold out in 2006 to Merck for 10 billion USD.

Bibliography: